Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“The 19th St. Gallen Conference took place this week in Vienna.
Nearly 80 expert panelists voted on key debated topics in breast oncology, selected by Harold J. Burstein & G Curigliano.
Here’s 10 key results from the SGBCC2025 consensus voting, divided by topic/breast cancer subtype.”
Rich Paxman, Chief Medical Officer and Managing Director at Paxman, reshared the post on X, adding:
“Delighted to see the consensus with regards to mitigating taxane-induced neuropathy (CIPN).
Looking forward to presenting further data later this year from Paxman in collaboration with NUS along with the ongoing SWOG Cancer Research Network trial ICECOMPRESS.”